Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Cavaliers Lose Varejao for NBA Season to Blood Clot on His Lung

Jan. 22 (Bloomberg) -- Cleveland Cavaliers center Anderson Varejao will miss the rest of the National Basketball Association season because of a blood clot in his right lung.

Varejao, 30, who averaged 14.1 points and 14.4 rebounds through 25 games, was admitted to the Cleveland Clinic last week and prescribed blood thinners. The team said he is expected to make a full recovery.

“We’re disappointed for Anderson and his family,” Cavaliers General Manager Chris Grant said in a statement on the team’s website yesterday. “We know how much he wants to be on the court helping his teammates.”

A native of Brazil, the 6-foot-11, 260-pound center was selected by the Orlando Magic in the second round of the 2004 NBA draft. He was acquired by the Cavs along with Drew Gooden and Steven Hunter from Orlando in a trade that year for Tony Battie and two second-round picks.

Varejao has averaged 7.7 points, 7.6 rebounds and 0.7 blocks through his nine-year career.

To contact the reporter on this story: Curtis Eichelberger in Wilmington, Delaware at ceichelberge@bloomberg.net

To contact the editor responsible for this story: Michael Sillup at msillup@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.